Sanofi Plans to Spin-off Active Pharmaceutical Ingredients (API)

Investingport
In February, Sanofi (SNY) made an announcement that it had intentions to spin off its drug ingredient manufacturing unit into a separate company. The spinoff would accommodate over 3,100 employees and own factories in the UK, Germany, Hungary, Italy, and France. Its existing 11 API facilities already subcontract for other drug companies. Sanofi intends that five of these facilities will be retained to manufacture APIs for Sanofi drugs while the remaining 6 factories will be spun off. The company went on to say that the active pharmaceutical ingredient (API) spinoff would be become the second-largest API globally, making sales of…
Source: Sanofi Plans to Spin-off Active Pharmaceutical Ingredients (API)

Please follow and like us:

Please follow & like us :)